Literature DB >> 3326412

Hypocomplementemic glomerulonephritis in an infant and mother. Evidence for an abnormal form of C3.

M A Linshaw1, F B Stapleton, F E Cuppage, J Forristal, C D West, R D Schreiber, C B Wilson.   

Abstract

A mother developed hematuria during the fourth month of pregnancy, and her nursing infant son from this otherwise uncomplicated pregnancy developed hematuria at 3.5 months of age. Both had a mild glomerulonephritis characterized by mesangial prominence, focal thickening and mottling of the glomerular basement membrane and electron-dense deposits, predominantly in the intramembranous and subendothelial positions. Immunofluorescence studies revealed striking accumulations of C3 and other complement components associated with alternative complement pathway activation within glomeruli, and the presence of small or equivocal amounts of immunoglobulin. C1q, C4 and factor B were not detectable. The glomerular lesion was accompanied by hypocomplementemia. Sera of both mother and infant displayed half normal levels of C3 and factor B, increased levels of C4, and normal levels of 12 other complement proteins. High normal or slight elevation in nephritic factor-like activity was observed in serial serum samples. Studies suggested that this mother and son represent the second kindred having an abnormal form of C3 which produces an alternative complement pathway C3 convertase, C3b, Bb, resistant to control by factor H. No additional affected family members were identified. The course of the nephritis over 7 years without drug therapy has been mild with resolving hematuria and no abnormal proteinuria or decrease in creatinine clearance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3326412     DOI: 10.1159/000167525

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  10 in total

1.  Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice.

Authors:  Fadi Fakhouri; Elena Goicoechea de Jorge; Frédérique Brune; Philippe Azam; H Terence Cook; Matthew C Pickering
Journal:  Kidney Int       Date:  2010-05-05       Impact factor: 10.612

2.  MPGN II--genetically determined by defective complement regulation?

Authors:  Christoph Licht; Ursula Schlötzer-Schrehardt; Michael Kirschfink; Peter F Zipfel; Bernd Hoppe
Journal:  Pediatr Nephrol       Date:  2006-09-23       Impact factor: 3.714

Review 3.  Dense deposit disease.

Authors:  Richard J H Smith; Claire L Harris; Matthew C Pickering
Journal:  Mol Immunol       Date:  2011-05-24       Impact factor: 4.407

4.  Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice.

Authors:  M C Pickering; J Warren; K L Rose; F Carlucci; Y Wang; M J Walport; H T Cook; M Botto
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-12       Impact factor: 11.205

Review 5.  Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach.

Authors:  An S De Vriese; Sanjeev Sethi; Jens Van Praet; Karl A Nath; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2015-07-16       Impact factor: 10.121

Review 6.  Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.

Authors:  M C Pickering; H T Cook
Journal:  Clin Exp Immunol       Date:  2008-02       Impact factor: 4.330

7.  Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phase.

Authors:  Danielle Paixão-Cavalcante; Steven Hanson; Marina Botto; H Terence Cook; Matthew C Pickering
Journal:  Mol Immunol       Date:  2009-05-02       Impact factor: 4.407

8.  Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice.

Authors:  Kirsten L Rose; Danielle Paixao-Cavalcante; Jennifer Fish; Anthony P Manderson; Talat H Malik; Anne E Bygrave; Tao Lin; Steven H Sacks; Mark J Walport; H Terence Cook; Marina Botto; Matthew C Pickering
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

Review 9.  Recent insights into C3 glomerulopathy.

Authors:  Thomas D Barbour; Matthew C Pickering; H Terence Cook
Journal:  Nephrol Dial Transplant       Date:  2013-03-10       Impact factor: 5.992

Review 10.  Dense deposit disease and C3 glomerulopathy.

Authors:  Thomas D Barbour; Matthew C Pickering; H Terence Cook
Journal:  Semin Nephrol       Date:  2013-11       Impact factor: 5.299

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.